Podcast Discusses Biotech Summit and China Competition
The weekly biotech podcast covered conversations from a recent health care and science summit. Topics included research publication practices and the role of AI in drug development.
ecns.cnThe episode of the biotech podcast examined discussions from STAT's Breakthrough Summit West. Attendees included leaders from health care and science sectors. BridgeBio's chief executive commented that the company is publishing structures that are not the right ones in its research publications.
An interview featured the chief executive of Retro Biosciences, a company backed by Sam Altman. The firm is preparing its first clinical data readout and is assessing how artificial intelligence may affect drug development. The hosts also discussed reporting on how competition from China is affecting the biotech sector and the approach of one self-appointed spokesperson.
Key Facts
Potential Impact
- 01
Listeners may gain information on biotech research practices and AI applications.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…